Thrombocytopenia 1 x blue arrangement only Screen (HIT-type II) Ensure fully HLA B27 2 x purple (2 Ag Negative / Ag 2 Weeks n/a labelled with at n/a NBS x 4 ml) Positive least 3 points of ID Ensure fully 2 x purple (2 HLA for Narcolepsy 2 Weeks n/a Negative / Positive labelled with at n/a NBS x 4 ml) least 3 points of ID Therapeutic Range INR Normal therapy 2.0 3.0 – 1 x blue 4 hours 1 hour 24 hours HDH (Warfarin High Thrombotic risk 3.0 monitoring) 4.5 – Positive / Negative / Intrinsic Factor Abs. 1 x gold 14 days NA TBC n/a SJUH Equivocal Contact By prior laboratory JAK 2 6 weeks 5 weeks See report n/a HMDS arrangement only (3068) For AMA, SMA, Liver Antibody 1 x gold 2 weeks n/a Negative / Positive LKM and GPC N/A LGI Screen antibodies Record country Negative / Positive (plus Malarial Parasites 1 x purple 4 hours 2 hours HDH visited & any species identification) prophylaxis on
Thrombocytopenia Screen (HIT-type II) 1 x blue arrangement only HLA B27 2 x purple (2 x 4 ml) 2 Weeks n/a Ag Negative / Ag Positive Ensure fully labelled with at least 3 points of ID n/a NBS HLA for Narcolepsy 2 x purple (2 x 4 ml) 2 Weeks n/a Negative / Positive Ensure fully labelled with at least 3 points of ID n/a NBS INR (Warfarin monitoring) 1 x blue 4 hours 1 hour Therapeutic Range Normal therapy 2.0 – 3.0 High Thrombotic risk 3.0 – 4.5 24 hours HDH Intrinsic Factor Abs. 1 x gold 14 days NA Positive / Negative / Equivocal TBC n/a SJUH JAK 2 Contact laboratory (3068) 6 weeks 5 weeks See report By prior arrangement only n/a HMDS Liver Antibody Screen 1 x gold 2 weeks n/a Negative / Positive For AMA, SMA, LKM and GPC antibodies N/A LGI Malarial Parasites 1 x purple 4 hours 2 hours Negative / Positive (plus species identification) Record country visited & any prophylaxis on HDH
HDFT-USER-HANDBOOK-rev-009.docx